Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research Progress on Regulating Intestinal Microbiota with Traditional Chinese Medicine to Treat Digestive System Tumors

Download as PDF

DOI: 10.23977/medsc.2024.050117 | Downloads: 7 | Views: 169

Author(s)

Long Jing 1, Shang Shuolin 1, Ma Gongxian 1, Xiao Meng 1, Wang Junhui 1, Wang Kai 1,2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Xi'an Chang'an District Hospital, Xi'an, Shaanxi, 710118, China

Corresponding Author

Wang Kai

ABSTRACT

The imbalance of intestinal microbiota homeostasis is closely related to the occurrence and development of digestive system tumors. Traditional Chinese medicine plays an important role in regulating intestinal microbiota and is used in the clinical prevention and treatment of digestive system tumors. This article reviews the research progress of traditional Chinese medicine in regulating intestinal microbiota to intervene in digestive system tumors. It reveals the important role of regulating intestinal microbiota in optimizing the treatment of digestive system tumors with traditional Chinese medicine, and provides a new direction and direction for the prevention and treatment of digestive system tumors.

KEYWORDS

Intestinal microbiota; traditional Chinese medicine; digestive system tumors; review

CITE THIS PAPER

Long Jing, Shang Shuolin, Ma Gongxian, Xiao Meng, Wang Junhui, Wang Kai, Research Progress on Regulating Intestinal Microbiota with Traditional Chinese Medicine to Treat Digestive System Tumors. MEDS Clinical Medicine (2024) Vol. 5: 112-119. DOI: http://dx.doi.org/10.23977/medsc.2024.050117.

REFERENCES

[1] Melina Arnold, Christian C. Abnet, Rachel E. Neale, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer [J]. Gastroenterology, 2020, 159(1):335-349. 
[2] Sung Hyuna, Ferlay Jacques, Siegel Rebecca L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA: A Cancer Journal for Clinicians, 2021, 71(3):209-249. 
[3] Zhou Jiachen, Zheng Rongshou, Wang Shaoming, et al. Comparison of the burden of major digestive tract tumors in China and some countries around the world in 2020 [J]. Electronic Journal of Comprehensive Cancer Therapy, 2021, 7(02): 26-32. 
[4] Zhou Hongyi, et al. Tumors and microbiota [J]. Esophageal Diseases, 2023, 5(02): 136-140.
[5] Jin Liangliang. Clinical analysis of adverse reactions after chemotherapy for tumor treatment with traditional Chinese medicine [J]. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2019, 7(34): 172, 181. 
[6] Chen Yanni, Wang Lanlan, Cha Qing, et al. Research progress of traditional Chinese medicine in tumor immunotherapy [J]. Liaoning Journal of Traditional Chinese Medicine, 2020, 47(4): 201-203.
[7] Aggarwal Nikhil, Kitano Shohei, Puah Ginette Ru Ying, et al. Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies [J]. Chemical reviews, 2022, 123(1):31-72.
[8] Morrison Douglas J, Preston Tom. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism [J]. Gut microbes, 2016, 7(3):189-200. 
[9] Jandhyala Sai Manasa, Talukdar Rupjyoti, Subramanyam Chivkula, et al. Role of the normal gut microbiota [J]. World journal of gastroenterology, 2015, 21(29):8787-8803. 
[10] Sadrekarimi Hourieh, Gardanova Zhanna R., Bakhshesh Morteza, et al. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora [J]. Journal of Translational Medicine, 2022, 20(1):301-301.
[11] Fulbright Laura E, Ellermann Melissa, Arthur Janelle C, et al. The microbiome and the hallmarks of cancer [J]. PLoS pathogens, 2017, 13(9):e1006480.
[12] Elinav Eran, Nowarski Roni, Thaiss Christoph A, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms [J]. Nature reviews. Cancer, 2013, 13(11):759-771. 
[13] Hu Bo, Friedman Gil, Elinav Eran, et al. Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice [J]. Oncoimmunology, 2019, 8(10):e981995.
[14] Couturier-Maillard Aurélie, Secher Thomas, Rehman Ateequr, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.[J]. The Journal of clinical investigation, 2013, 123(2):700-711. 
[15] Dejea Christine, Wick Elizabeth, Sears Cynthia L, et al. Bacterial oncogenesis in the colon [J]. Future microbiology, 2013, 8(4):445-460.
[16] Jean Guy LeBlanc, Christian Milani, Graciela Savoy de Giori, et al. Bacteria as vitamin suppliers to their host: a gut microbiota perspective [J]. Current Opinion in Biotechnology, 2013, 24(2):160-168.
[17] Vrieze A, Holleman F, Zoetendal E G, et al. The environment within: how gut microbiota may influence metabolism and body composition [J]. Diabetologia, 2010, 53(4):606-613.
[18] Heather L. Cash, Cecilia V. Whitham, Cassie L. Behrendt, et al. Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin [J]. Science, 2006, 313(5790):1126-1130.
[19] Eslami Majid, Yousefi Bahman, Kokhaei Parviz, et al. Importance of probiotics in the prevention and treatment of colorectal cancer [J]. Journal of cellular physiology, 2019, 234(10):17127-17143. 
[20] Cai Ziwei, Kang Bai. On the unity of principles between traditional Chinese medicine and microecology [J]. Chinese Journal of Microecology, 1995(04):43-48+55. 
[21] Ding Fengmei, Xing Haitao, Zhao Jingli. Research progress on the adjustment of intestinal microecology by traditional Chinese medicine [J]. Journal of Traditional Chinese Medicine, 2022, 50(04): 79-85.
[22] Jiang Ruiyuan, Lan Qiaoyu, Wang Wei, et al. Effects of spleen deficiency and inflammatory state on the intestinal flora of liver cancer tumor-bearing mice and the intervention effect of Jianpi Yiqi prescription [J]. Chinese Journal of Traditional Chinese Medicine, 2023, 38(01):341-347. 
[23] Yang He. Observation on the efficacy of Fuzheng Xiaoliu Recipe on stage III primary liver cancer and its impact on intestinal flora [D]. Henan University of Traditional Chinese Medicine, 2022.
[24] Han Dandan, Hu Minfang, Yu Can. Diwu Yanggan Recipe regulates the TLR4/NF-κB signaling pathway on the regulation of intestinal flora in liver cancer models [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2023, 25 (11): 68-72. 
[25] Tian Li, Wan Duanjing, Wen Yangmin. Effect of salvianolic acid B on TLR4/MyD88/NF-κB pathway and intestinal bacteria in liver cancer H22 mice [J]. World Science and Technology-Modernization of Traditional Chinese Medicine, 2023, 25(05)):1871-1878. 
[26] Gao Xiaoxia, Guo Chunxia, Xie Yuanyuan, et al. Tumor inhibitory effect of cryptotanshinone on liver cancer transplanted mice and its effect on intestinal flora and peripheral blood lymphocyte subtypes [J]. Journal of Clinical and Experimental Medicine, 2022, 21(17):1798-1801. 
[27] Zhang Yumei, Zhu Lin, Shi Jian, et al. Effects of Yinchenhao decoction on liver bile acids and intestinal microecology in mice with orthotopic transplantation of liver cancer [J]. Guangming Traditional Chinese Medicine, 2022, 37(16): 2939-2942. 
[28] Jin Liang, Li Huijie, Wang Xin, et al. Research status of intestinal flora and colorectal cancer occurrence and the regulatory effect of traditional Chinese medicine [J]. Modern Oncology, 2022, 30(18): 3412-3415. 
[29] Lin Qingguo, Wang Tianming, Ji Yuxian, et al. Effect of Dahuang Mudan Decoction on intestinal flora and Th1/Th2 cytokines in patients with colorectal cancer after surgery [J]. New Chinese Medicine, 2023, 55(20):25-30. 
[30] Meng Chunqin, Liu Xianyong, Wu Hao, et al. The efficacy of Jianpihuayu prescription in the treatment of colorectal cancer with spleen deficiency and blood stasis and its impact on intestinal flora and immune function [J]. Hebei Traditional Chinese Medicine, 2023, 45(06) ):944-947+951. 
[31] Dai Lingling, Hou Aihua, Dou Huanhuan, et al. Clinical study on the treatment of patients with metastatic colorectal cancer undergoing chemotherapy with spleen deficiency and phlegm stasis syndrome using Yichang Sanjie Recipe [J]. Journal of Traditional Chinese Medicine Oncology, 2023, 5(04): 33-40.
[32] Jiang Yiqian. Study on the mechanism of Sanwubaisan inhibiting the development of colorectal cancer by regulating intestinal flora and TLR4/COX-2/PGE-2 pathway [D]. Nanjing University of Traditional Chinese Medicine, 2023. 
[33] Xie Hui, Zhou Hongguang, Li Li, et al. Exploring the anti-colon cancer mechanism of Iron Pills based on intestinal flora [J]. Journal of Shandong University of Traditional Chinese Medicine, 2023, 47(01): 56-63.
[34] Wang Nan, Fang Xinggang, Liao Sha, et al. Study on the mechanism of action of Gegen Qinlian decoction on intestinal flora in colon cancer model rats based on Wnt/β-catenin signaling pathway [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2023, 25(02):49-53.
[35] Ouyang Qingwu, Fei Yan, Wei Yunjiao, et al. Regulatory effect of Sijunzi decoction on intestinal flora and immune function in mice with colon cancer [J]. Chinese Journal of Gerontology, 2021, 41(21): 4819-4823. 
[36] Wang Jialin, et al. Mechanism of Compound Lizard Powder Gel in regulating intestinal flora in treating gastric precancerous lesions in PLGC rats [J]. Chinese Journal of Gerontology, 2023, 43(13): 3192-3197. 
[37] Dai Lin, Zhang Wanlin, Hu Xiaolian. Effect of Jianpi Fuzheng Jiedu Decoction on Tumor Markers, Immune Function and Intestinal Flora in Patients with Advanced Gastric Cancer Chemotherapy [J]. Liaoning Journal of Traditional Chinese Medicine, 2023, 50(07): 120-123. 
[38] Sun Wenjia. Clinical study on the effect of Jianpi Yangzhengxiaozheng Recipe on intestinal flora in patients with intermediate and advanced gastric cancer undergoing chemotherapy [D]. Nanjing University of Traditional Chinese Medicine: 2022. 
[39] Chen Yaling, Chen Xu, Zhang Ruijuan, et al. Study on the Effect of Modified Buzhong Yiqi Prescription on Intestinal Flora of Gastric Tumor Carrying Mice Based on 16S rRNA High-throughput Sequencing Technology [J]. Jiangsu Journal of Traditional Chinese Medicine, 2022, 54(08):70-75. 
[40] Bai Xing, Cheng Fan'e, Yang Changyuan, et al. Mechanism of Eremias multiocellata on inhibiting gastric cancer with liver metastasis based on SNAIL signaling pathway and gut microbiota [J]. Chinese Traditional and Herbal Drugs, 2023, 54(03): 825-833.

Downloads: 4545
Visits: 196784

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.